Nutritional therapy for persistent cognitive impairment after resolution of overt hepatic encephalopathy in patients with cirrhosis: A double‐blind randomized controlled trial

Minimal hepatic encephalopathy (MHE) reflects cognitive impairment in patients with liver cirrhosis and is associated with poor prognosis. We assessed the effects of nutritional therapy on cognitive functions, health‐related quality of life (HRQOL), anthropometry, endotoxins, and inflammatory markers in cirrhotic patients with MHE.

• Publication year

  2023

• Venue

  Journal of Gastroenterology and Hepatology

• Publication date

  2023-06-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/jgh.16266PMID 37354045
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A double blind randomized controlled trial to assess efficacy of nutritional therapy for prevention of recurrence of hepatic encephalopathy in patients with cirrhosis

  2022cited by this paper
• Prognostic value of the third lumbar skeletal muscle mass index in patients with liver cirrhosis and ascites.

  2020cited by this paper
• Personalized Nutrition Through The Gut Microbiota: Current Insights And Future Perspectives.

  2020cited by this paper
• Sarcopenia and Liver Cirrhosis—Comparison of the European Working Group on Sarcopenia Criteria 2010 and 2019

  2020influential reference
• EASL Clinical Practice Guidelines on nutrition in chronic liver disease.

  2019cited by this paper
• Elevated serum myostatin level is associated with worse survival in patients with liver cirrhosis

  2017cited by this paper
• Efficacy of Nutritional Therapy for Patients With Cirrhosis and Minimal Hepatic Encephalopathy in a Randomized Trial.

  2016cited by this paper
• Probiotic VSL#3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial.

  2014cited by this paper
• Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver

  2014cited by this paper
• Probiotics prevent hepatic encephalopathy in patients with cirrhosis: a randomized controlled trial.

  2014cited by this paper
• Nutritional management contributes to improvement in minimal hepatic encephalopathy and quality of life in patients with liver cirrhosis: A preliminary, prospective, open‐label study

  2013cited by this paper
• The nutritional management of hepatic encephalopathy in patients with cirrhosis: International society for hepatic encephalopathy and nitrogen metabolism consensus

  2013cited by this paper
• Gut microbiota and hepatic encephalopathy

  2013cited by this paper
• Linkage of gut microbiome with cognition in hepatic encephalopathy.

  2012cited by this paper
• Muscle depletion increases the risk of overt and minimal hepatic encephalopathy: results of a prospective study

  2012cited by this paper
• A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy

  2011cited by this paper
• Rifaximin in the treatment of hepatic encephalopathy

  2011cited by this paper
• Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis.

  2011cited by this paper
• Interorgan ammonia metabolism in liver failure: the basis of current and future therapies

  2011cited by this paper
• Breakfast improves cognitive function in cirrhotic patients with cognitive impairment.

  2010cited by this paper
• Effect of long‐term late‐evening snack on health‐related quality of life in cirrhotic patients

  2010cited by this paper
• Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy.

  2010cited by this paper
• Rifaximin treatment in hepatic encephalopathy.

  2010cited by this paper
• Nutrition in hepatic encephalopathy.

  2010cited by this paper
• Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhosis: An Open-Label, Randomized Controlled Trial of Lactulose, Probiotics, and No Therapy

  2010cited by this paper
• Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo.

  2009cited by this paper
• Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosis: A randomized 12‐month trial

  2008cited by this paper
• Lactulose improves cognitive functions and health‐related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy

  2007cited by this paper
• Bifidobacterium longum with Fructo-Oligosaccharide (FOS) Treatment in Minimal Hepatic Encephalopathy: A Randomized, Double-Blind, Placebo-Controlled Study

  2007cited by this paper
• European Association for the Study of the Liver

  2006cited by this paper
• Improvement of hepatic encephalopathy using a modified high-calorie high-protein diet.

  2005cited by this paper
• Comparison between handgrip strength, subjective global assessment, and prognostic nutritional index in assessing malnutrition and predicting clinical outcome in cirrhotic outpatients.

  2005cited by this paper
• Effects of an appropriate oral diet on the nutritional status of patients with HCV-related liver cirrhosis: a prospective study.

  2005cited by this paper
• Synbiotic modulation of gut flora: Effect on minimal hepatic encephalopathy in patients with cirrhosis

  2004cited by this paper
• Nocturnal energy and BCAA supplementation in patients with liver cirrhosis.

  2004cited by this paper
• Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis.

  2004cited by this paper
• Critical flicker frequency for quantification of low‐grade hepatic encephalopathy

  2002cited by this paper
• Quality of Life in Cirrhotics with Minimal Hepatic Encephalopathy

  2001cited by this paper
• Efficacy of Lactulose in Cirrhotic Patients with Subclinical Hepatic Encephalopathy

  2000cited by this paper
• Clinical features and survivial of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests

  1999cited by this paper
• Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study.

  1998cited by this paper
• Subclinical hepatic encephalopathy impairs daily functioning

  1998cited by this paper
• Clinical efficacy of lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy

  1997cited by this paper
• Lactulose improves psychometric testing in cirrhotic patients with subclinical encephalopathy

  1997cited by this paper
• Evaluation of neuropsychological function in patients with liver cirrhosis with special reference to their driving ability

  1995cited by this paper
• Latent portasystemic encephalopathy

  1981cited by this paper

• Steatotic liver disease trajectory: A holistic EASL guidance on the multidisciplinary approach to screening and patient management☆

  2026cites this paper
• ACG Clinical Guideline: Hepatic Encephalopathy.

  2026cites this paper
• Chinese Consensus on Clinical Diagnosis and Management of Covert Hepatic Encephalopathy

  2025influential citation
• "Effectiveness of Oral Nutritional Therapy in Cirrhosis: A Systematic Review and Meta-Analysis of Clinical and Functional Outcomes".

  2025cites this paper
• EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

  2024cites this paper
• EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD).

  2024cites this paper